Qpex Biopharma Inc., a Shionogi Group Company, has appointed Gareth Morgan, MS, MBA, most recently SVP and Global Head of Portfolio Management and AMR Policy at Shionogi Inc., as President of Qpex. Morgan succeeds Michael Dudley, Pharm.D., who has retired and stepped down from his role as President and CEO. Dudley will continue to serve as a strategic advisor to Qpex and Shionogi. About Gareth Morgan Prior to joining Shionogi in 2007, Morgan held clinical development and project managem...